HomeNuminus Wellness Inc.

Numinus Wellness Inc.

Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment

Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment

May 17, 2022

Numinus Announces the Music as Medicine Event Series

Numinus Announces the Music as Medicine Event Series

April 29, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

April 12, 2022

Numinus MAPS-Sponsored PTSD Trial Moves to Next Phase

Numinus MAPS-Sponsored PTSD Trial Moves to Next Phase

March 30, 2022

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

March 30, 2022

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

March 1, 2022

Numinus to Participate in AAAS 2022 Annual Meeting on February 17-20, 2022

Numinus to Participate in AAAS 2022 Annual Meeting on February 17-20, 2022

February 10, 2022

Numinus Appoints New Bioscience Advisors to Advance IP Development

Numinus Appoints New Bioscience Advisors to Advance IP Development

February 2, 2022

Numinus Wellness Inc. Graduates to the OTCQX Best Market

Numinus Wellness Inc. Graduates to the OTCQX Best Market

January 27, 2022

Numinus Receives Approvals to Start Recruiting Participants in MAPS PBC Study

Numinus Receives Approvals to Start Recruiting Participants in MAPS PBC Study

January 26, 2022

1 2 3 … 5 »